Provisional Timetable Tuesday 20th 8.30 AM Welcome and Introduction Meeting procedures, Election of the Chairperson
Keith Sumption
Update on EUFMD Commission and ongoing/planned actions under the EUFMD Strategic Plan 2005-8 and ECFAO agreement Summary of Research group Action Plan 2003-5
Keith Sumption
10.30
FMD risk and the review of priority antigens FMD risk and the review of priority antigens for European vaccine banks [update on relevant cross-protection tests requested] Break Question: Risk of FMDV type Asia-1 to Turkey FMD Surveillance report – risk situation in Central Asia1
11.00
FMD Surveillance report – risk situation in I.R of Iran
11.30
Sero-monitoring for FMD infection in the Trans Caucasus Discussion. Timetable for discussion of remaining surveillance items2 Identify reporting/working groups Lunch Tour of Greifswald and bus to FLI Reporting/working groups3. At FLI Dinner at FLI Return to hotel If return earlier 21:00, then presentations may be made 21:00-22:00
9.30
10.10
12.00 12.30 14.00 16.30 18.30 22:00
Update from surveillance actions FMD surveillance in Turkey – progress report from surveillance actions in Erzurum province FMD surveillance in Turkey – progress report from sero-surveillance in Thrace region Wednesday 21st 8.30 am
Co-ordinator or presenter
Question: what is the demand and who can supply the needs for external quality assurance of FMD labs? in our region Inter-laboratory laboratory proficiency detection tests
Kris de Clercq
David Paton
Manzoor Hussain, FAO Regional epidemiologist Maghsoud Jamdar/Francis Geiger Carsten Pötzsch
Tom Murray & Sinan Aktas Sinan Aktas
Kris
David
1 Paper on FMD in Tajikistan may be fitted here (Erika Carlsson, FAO animal health officer Tajikistan) 2 Monitoring situation in Turkey International Surveillance gaps and priorities International networking and issues in surveillance- OIE/FAO FMD network Other surveillance and control issues –Question of global cessation of Type C vaccination 3 To be decided by Chairman and will relate to need for specific reports for example R/WG on Asia-1 risk R/WG on international surveillance gaps R/WG on the needs of European NRLs /experts/labs within a global FMD network.
15
